Research Progress of Pharmacological Therapy and Nutritional Support for Cachexia in Lung Cancer Patients / 中国肺癌杂志

Cachexia is a common complication in patients with lung cancer. It aggravates the toxic and side effects of chemotherapy, hinders the treatment plan, weakens the responsiveness of chemotherapy, reduces the quality of life, increases complications and mortality, and seriously endangers the physical and mental health of patients with lung cancer. The causes and pathogenesis of tumor cachexia are extremely complex, which makes its treatment difficult and complex. Controlling cachexia in lung cancer patients requires many means such as anti-tumor therapy, inhibition of inflammatory response, nutritional support, physical exercise, and relief of symptoms to exert the synergistic effect of multimodal therapy against multiple mechanisms of tumor cachexia. To date, there has been a consensus within the discipline that no single therapy can control the development of cachexia. Some therapies have made some progress, but they need to be implemented in combination with multimodal therapy after fully assessing the individual characteristics of lung cancer patients. This article reviews the application of drug therapy and nutritional support in lung cancer patients, and looks forward to the research direction of cachexia control in lung cancer patients.
.

Cardiac Cachexia: Perspectives for Prevention and Treatment / Caquexia Cardíaca: Perspectivas para a Prevenção e Tratamento

Abstract Cachexia is a prevalent pathological condition associated with chronic heart failure. Its occurrence predicts increased morbidity and mortality independent of important clinical variables such as age, ventricular function, or heart failure functional class. The clinical consequences of cachexia are dependent on both weight loss and systemic inflammation, which accompany cachexia development. Skeletal muscle wasting is an important component of cachexia; it often precedes cachexia development and predicts poor outcome in heart failure. Cachexia clinically affects several organs and systems. It is a multifactorial condition where underlying pathophysiological mechanisms are not completely understood making it difficult to develop specific prevention and treatment therapies. Preventive strategies have largely focused on muscle mass preservation. Different treatment options have been described, mostly in small clinical studies or experimental settings. These include nutritional support, neurohormonal blockade, reducing intestinal bacterial translocation, anemia and iron deficiency treatment, appetite stimulants, immunomodulatory agents, anabolic hormones, and physical exercise regimens. Currently, nonpharmacological therapy such as nutritional support and physical exercise are considered central to cachexia prevention and treatment.

Resumo Caquexia é condição patológica prevalente em pacientes com insuficiência cardíaca (IC) associada. Sua ocorrência constitui marcador de gravidade da doença e está associada a aumento da morbidade e mortalidade independentemente de variáveis clínicas importantes como idade, função ventricular ou classe funcional da IC. As consequências clínicas da caquexia dependem tanto da perda de peso como da inflamação sistêmica que acompanha seu desenvolvimento. Perda da musculatura esquelética é importante componente da caquexia; ela frequentemente precede o desenvolvimento desta condição e está associada a mau prognóstico da IC. A caquexia afeta vários órgãos e sistemas. Sua origem é multifatorial; como os mecanismos fisiopatológicos envolvidos em seu desenvolvimento não estão completamente entendidos, há grande dificuldade no desenvolvimento de terapia específica para a prevenção e tratamento. Estratégias para a prevenção visam, principalmente, a preservação da massa muscular. Diferentes opções de tratamento têm sido descritas, a maioria delas avaliada em estudos experimentais ou pequenos estudos clínicos. Estas incluem suporte nutricional, bloqueio de sistemas neuro-hormonais, redução de translocação bacteriana intestinal, tratamento da anemia e ferrodeficiência, estimulantes de apetite, agentes imunomodulatórios, hormônios anabólicos, e diferentes programas de exercícios físicos. Atualmente, a terapia não farmacológica como o suporte nutricional e exercícios físicos tem sido considerada de grande importância na prevenção e tratamento da caquexia associada à IC.

Caquexia associada à insuficiência cardíaca / Heart failure-induced cachexia

Pacientes com insuficiência cardíaca frequentemente desenvolvem estado de caquexia, que constitui fator independente de redução da sobrevida. Caquexia pode ser diagnosticada quando ocorre perda de peso corporal maior que 6% do peso habitual, na ausência de outras doenças. Embora sua fisiopatologia não esteja completamente esclarecida, vários fatores parecem estar envolvidos, como diminuição da ingestão alimentar, anormalidades do trato gastrointestinal, ativação imunológica e neuro-hormonal e alteração da relação entre processos anabólicos e catabólicos. Como não há terapia específica para a caquexia associada à insuficiência cardíaca, o tratamento baseia-se no suporte nutricional, bloqueio neuro-hormonal, controle do edema e anemia e exercícios físicos. Fármacos com propriedades imunomodulatórias e anabólicas encontram-se em investigação clínica e experimental.

Heart failure patients often develop cachexia, which is an independent factor for survival reduction. Cachexia can be diagnosed when there is loss of more than 6% of the body weight, in the absence of other diseases. Even though its pathophysiology has not yet been completely clarified, various factors seem to be involved, such as reduction in food consumption, gastrointestinal tract abnormalities, immunologic and neuro-hormonal activarion and changes in the relationship between anabolic and catabolic processes. Since there is not specific therapy for heart failure-induced cachexia, management is based on nutritional support, neuro-hormonal blockade, control of edema and anemia and exercise. Drugs with anabolic and immunomodulating properties are being evaluated and clinical and non-clinical trials.

Curso de Reumatologia: aula 2: Importância Clínica da Caquexia Reumatoide / Course of Rheumatology: class 2: Clinical importance of rheumatoid arthistis

A artrite reumatoide é doença autoimune sistêmica de etiologia ainda desconhecida que pode causar destruição de cartilagem e osso. Afeta aproximadamente 1 por cento da população e é duas a três vezes mais frequente nas mulheres do que nos homens. Apesar de agredir predominantemente as articulações, apresenta inúmeras manifestações sistêmicas, entre elas a caquexia - que se manifesta em aproximadamente 66 por cento dos pacientes reumatoides. A caquexia reumatoide é conceituada como perda involuntária de massa celular, predominantemente de músculo esquelético, mas que também ocorre em vísceras e sistema imune. A causa é multifatorial, mas os mecanismos mais importantes são a produção de citocinas, principalmente TNFα e II-1ß, diminuição da ação periférica da insulina e pouca atividade física. Neste artigo discutem-se aspectos relacionados à patogenia, às implicações clínicas e abordagens terapêuticas.

Rheumatoid arthristis is a chronic, systemic, autoimmune disease of unknow etiology that causes destruction of joint cartilage and bone. It affects approximately 1 per cent of the population and predominates among womwn than men. Cachexia, from the Greek "bad condition", generally connotes as state of advanced malnutrition and wasting. However, more recently cachexia has been used to denote the loss of body cell mass which occurs in illness. So rheumatoid cachexia can be defined as an involuntary loss of body cell mass, that predominates in skeletal muscle, and occurs with little or no wegith in the presence of stable or increased fat mass. The etiology is likely multifactorial, and involves excess inflamatory cytokine production, namely excess tumor necrosis factor-α and interleukin-1ß production; reduced peripheral insulin action; and low habitual physical activity. In this article, we evaluate pathogenesis of rheumotoid cachexia, its clinical disclosures and discuss potential therapies.

Síndrome de anorexia-caquexia en el paciente oncológico / The cachexia-anorexia syndrome among oncological patients

Se estima que dos terceras partes de los pacientes con cáncer sufren anorexia o pérdida significativa de apetito, lo que conduce a pérdida acentuada de peso y a desnutrición grave (caquexia), una de las principales causas contribuyentes de la muerte. Se ha observado que el síndrome de anorexia-caquexia en cáncer difiere de la desnutrición simple, si bien aún no se conocen los mecanismos exactos que lo ocasionan. Diversas hipótesis proponen que la patogénesis es multicausal, destacándose diversas características del tumor, del huésped y variables del tratamiento. Desafortunadamente, con frecuencia la pérdida acentuada de peso representa para el paciente la progresión del proceso de la enfermedad, lo que puede tener repercusiones significativas en su calidad de vida y en sus interacciones familiares y sociales. Se lleva a cabo una revisión bibliográfica de los procesos etiológicos del síndrome, así como de las posibles medidas terapéuticas y farmacológicas.

Approximately two thirds of cancer patients at advanced stages of the disease suffer from anorexia, which leads to significant weight loss and progressive cachexia, an important factor that contributes to death. It has been observed that cancer cachexia differs from simple starvation, although the exact mechanisms associated with cancer cachexia are not well known. Several theories regarding its pathogenesis point to a complex mixture of tumor, host and treatment variables. Unfortunately, the wasting syndrome also constitutes for the patient, a progression of the cancer process, significantly affecting quality of life and social interactions. Treatable causes should be identified and treated. Knowledge of the mechanisms underlying the effects of caquexia on the patient may play a role in identifying treatment measures targetted to muscle wasting and to maintain body strength. In this article we review the main features and mechanisms of the anorexia-cachexia syndrome in patients with cancer.

The Role of Long-Chain Polyunsaturated Fatty Acids in the Treatment of Cancer Cachexia and Tumour Growth in Patients with Malignant Diseases : a Review

Recent studies show that u-3 polyunsaturated fatty acids (PUFAs) have the capacity to modulate cancer outcomes. The body responds to cancer in the same way that it responds to inflammation and wound healing. Nutrients with anti-inflammatory effects could therefore be expected to play a role in cancer treatment. This review focuses on the role of u-3 PUFAs in tumourigenesis and cancer cachexia. Studies indicate that eicosapentaenoic acid (EPA) supplementation may promote arrest of tumour growth and reduce cell proliferation. Patients need to consume at least 2 g of EPA per day for it to have a therapeutic effect. Positive outcomes related to cachexia include diminished weight loss; increased appetite; improved quality of life and prolonged survival; although there is controversy regarding these clinical outcomes. The effects of u-3 PUFAs on tumourigenesis and cachexia are viewed in the context of altered lipid and protein metabolism. This altered metabolism usually experienced by cancer patients results in increased formation of proinflammatory eicosanoids and cytokines. Cytokines play an indirect role by stimulating the production of arachidonic acid-derived eicosanoids; which support inflammation; cell proliferation and angiogenesis; and inhibit apoptosis. It can be concluded that u-3 PUFA supplementation offers a means of augmenting cancer therapy; inhibiting tumouri- genesis and possibly contributing to cachexia alleviation

Reconhecendo os distúrbios do comportamento alimentar, do peso corporal e da nutriçäo em Medicina interna: aspectos terminológicos, fisiopatológicos e semiológicos: parte 1 / Recognizing of feeding behavior desorders, os body weight and of nutrition in internal medicine: terminological, physiopathological and semiological aspects: part 1

Perda de apetite (anorexia), emagrecimento e ganho de peso são alguns dos freqüentes sintomas e sinais que compõem o cortejo de alterações do estado geral dos pacientes. De caráter subjetivo e significado inicial vago, tais desordens passam a apresentar maior interesse semiológico e diagnóstico à medida que são detalhadas no interrogatório e integradas aos outros elementos anamnésicos de um doente (inquérito alimentar, oscilações ponderais, fármacos utilizados). Compreendê-las em seus mecanismos fisiopatológicos íntimos, mesmo que de maneira incompleta, constitui privilégio recente, de poucas décadas. Grande parte desses avanços devem-se à Biologia Molecular. No presente artigo são discutidos aspectos hormonais e metabólicos dos distúrbios comportamentais alimentares e ponderais, enquanto causadores e (ou) resultantes de desnutrição, vistos de vários ângulos (várias especialidades) da Medicina Interna; de permeio, a terminologia pertinente está igualmente abordada

Palliative care education and training during residency: a survey among residents at a tertiary care hospital.

BACKGROUND: Palliative care is the active total care of patients in advanced and incurable stages of cancer. More than 70% of all cancer patients in India require palliative care for relief of pain, other symptoms and psychosocial distress. The need for education and training in palliative care has been emphasized by the World Health Organization (WHO) during the past 15 years. This survey aimed to assess the awareness, clinical knowledge, and education and training aspects of palliative care among the clinical residents of a tertiary care hospital. METHODS: During January and February 1999, a total of 100 residents were asked to respond to a questionnaire on palliative care education and training during residency. The questionnaire consisted of 10 questions (each question with 3 different responses). Awareness regarding palliative care was assessed by 3 questions; clinical knowledge by 4 questions; and education and training obtained during residency by 3 questions. Comparisons were made using the Chi-square test between the oncology and non-oncology resident groups. RESULTS: Forty-nine residents (23 oncology and 26 non-oncology) responded to the survey. Awareness that palliative care involves active total care was lacking in 8 (16%) residents. The cost of palliative care in India was considered high by 17 (65%) non-oncology residents and 21 (43%) of the whole group. Hospice, as the right place for palliative care, was chosen by 14 (61%) oncology and 3 (11.5%) non-oncology residents (p = 0.0003). In the whole group, 21 (43%) believed that palliative care could be provided on an outpatient basis. Pain, depression and cachexia were identified as the most distressing symptoms of patients with incurable cancer. Seventeen (83%) oncology and 4 (15%) non-oncology residents (p = 0.000) knew how to use the WHO step-ladder for cancer pain relief. All oncology residents and 10 (38%) non-oncology residents preferred the oral route for providing medications for pain relief (p = 0.0001). The didactic education and training imparted during residency was considered as 'not enough' by 39% of oncology and 62% of non-oncology residents (51% overall). The confidence to deliver quality palliative care was lacking in 43% and 58% of oncology and non-oncology residents, respectively. CONCLUSION: Clinicians in India need to be provided focused skills and training for them to be able deliver quality palliative care to the large number of patients with incurable cancer. The cost of palliative care and the optimum place to deliver it, the symptoms of advanced cancer, pain relief and symptom control methods and quality of life in end-stage cancer patients are some aspects that should be an integral part of clinical residency programmes.

Conducta alternativa en pacientes con cáncer colorrectal asociado a desnutrición secundaria grave / Alternative management in patients with colorectal cancer associated to severe secondary malnutrition

El objetivo es analizar la conducta tomada con dos pacientes portadoras de cáncer de colon con desnutrición grave que no mejoró con las medidas nutricionales habituales. Se presentan los casos clínicos de dos pacientes describiendo su cuadro clínico, los balances nutricionales y los aportes para revertir sus cuadros de desnutrición. Al ver que no regresa se decide hacer una resección de colon con intención curativa y en un segundo tiempo restablecer el tránsito. Em ambas pacientes, resecando el tumor se pudo mejorar su desnutrición. Se discuten las causas de desnutrición en pacientes con cánceres de colon y otras localizaciones